MALVERN, PA — Neuronetics Inc. (Nasdaq: STIM) will report third-quarter 2026 financial and operating results on November 4, giving investors an update on its combined medical technology and psychiatric treatment business, which includes NeuroStar magnetic stimulation systems and the Greenbrook clinic network.
The Malvern-based company said it will release its results before U.S. financial markets open Wednesday, followed by a management conference call at 8:30 a.m. Eastern Time.
The report will cover a business that combines the development and commercialization of transcranial magnetic stimulation, or TMS, technology with direct patient care through Greenbrook’s network of interventional psychiatry clinics.
Neuronetics markets NeuroStar Advanced Therapy, a noninvasive treatment that uses magnetic stimulation to target areas of the brain associated with depression.
The system has received clearance from the U.S. Food and Drug Administration for treating major depressive disorder in adults and as an adjunctive treatment for obsessive-compulsive disorder in adults.
Its clearances also include reducing anxiety symptoms in adults with major depressive disorder and accompanying anxiety symptoms, as well as first-line adjunctive treatment for major depressive disorder in patients ages 15 to 21.
Through Greenbrook, Neuronetics operates a U.S. network of psychiatric treatment centers offering TMS and SPRAVATO (esketamine) nasal spray.
SPRAVATO is approved for adults with treatment-resistant depression, either as a standalone treatment or alongside an oral antidepressant.
The medication is also indicated, in conjunction with an oral antidepressant, for depressive symptoms in adults with major depressive disorder who have acute suicidal ideation or behavior.
The combination of NeuroStar technology and Greenbrook treatment centers gives Neuronetics operations spanning both medical equipment and clinical services.
Investors can access the November 4 earnings webcast at https://edge.media-server.com/mmc/p/pby6nj3b.
Telephone participants can register at https://register-conf.media-server.com/register/BIfb15d126ea12489b8393c8409cb96558.
The company recommends joining approximately 10 minutes before the scheduled conference call.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.